missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Deucravacitinib, MedChemExpress
Description
Deucravacitinib (BMS-986165) is a highly selective, orally bioavailable allosteric TYK2 inhibitor for the treatment of autoimmune diseases, which selectively binds to TYK2 pseudokinase (JH2) domain (IC50=1.0 nM) and blocks receptor-mediated Tyk2 activation by stabilizing the regulatory JH2 domain. Deucravacitinib inhibits IL-12/23 and type I IFN pathways.
Specifications
Specifications
| Nombre del producto químico o material | Deucravacitinib |
| CAS | 1609392-27-9 |
| Color | Light Yellow |
| Notas de grado de pureza | Research |
| Fórmula molecular | C20H19D3N8O3 |
| Cantidad | 50 mg |
| Sinónimo | BMS-986165 |
| Información de solubilidad | DMSO : 37.5 mg/mL (88.14 mM; Need ultrasonic) |
| SMILES | O=C(C1=NN=C(NC(C2CC2)=O)C=C1NC3=CC=CC(C4=NN(C)C=N4)=C3OC)NC([2H])([2H])[2H] |
| Peso molecular (g/mol) | 425.46 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?